A class of host cell proteins that restrict viral infection, previously shown to inhibit the entry of HIV-1 into healthy cells, have now been demonstrated to...
The job reduction was announced the same day that Theravance acknowledged that its wholly-owned symptomatic neurogenic orthostatic hypotension (nOH) candidate ampreloxetine (TD-9855) failed the Phase III...
The future of vaccines may look more like eating a salad than getting a shot in the arm. UC Riverside scientists are studying whether they can...
Hong Kong-based Prenetics plans to use a cash infusion from its tie-up with a blank-cheque company backed by Adrian Cheng Chi-kong, the third-generation scion of one...
One strategy for selecting top stocks is to follow a known market guru, a high-profile, highly successful investor. These are the pros who have built multi-billion...
Effective science teachers use everyday natural events to get students to explore their world. Here’s how they do it, according to an expert who prepares elementary...
A breakdown of everything to know about how to invest in life science — from biotech and pharmaceuticals to medical devices and genetics. The post How to...
The controversy surrounding Covid-19's origin continues to heat up, as the National Institutes of Health's recent removal of genetic data about the novel coronavirus virus from...
Israel To Conduct COVID "Genetic Scanning" For All Inbound Air Passengers The world's most "ultra-vaxxed nation" Israel is continuing to struggle to keep its coronavirus infections down,...
Making rapid antigen tests for COVID-19 cheaper and more accessible can catch the infectious cases before they spread and help everyone resume normal activities safely.
Making rapid antigen tests for COVID-19 cheaper and more accessible can catch the infectious cases before they spread and help everyone resume normal activities safely.
Two different respiratory viruses were found to swap proteins when they infected the same cell.
Intelligence Community Assessment On COVID-19 Origins Ignores Readily Available Information Authored by Jeff Carlson and Hans Mahncke via The Epoch Times, In May 2021, President Joe...
Roche bolstered the Swiss pharma giant's diagnostics capabilities by acquiring the company's long-term partner, TIB Molbiol. The procurement will expand Roche's PCR-test portfolio capabilities in the ongoing fight against...
When the coronavirus copies itself, there is a chance its RNA will mutate. But new variants must jump from one host to another, and the more...
The global stem cell therapy market is expected to experience significant growth over the next few years. Here are the 10 top stem cell companies on...
MIT buddy biologists Omar Abudayyeh and Jon Gootenberg were sitting in the Quebec Convention Center at the annual CRISPR conference in 2019 when, buried in a...
Germany Is Just A Distraction From The Real Story Authored by Bill Blain via MorningPorridge.com, “The bloody uproar of war is over; let’s enjoy the carnival...
India Approves World's First DNA-Based COVID Vaccine Shortly after Taiwan announced that it had successfully produced its own vaccine as it seeks to bolster its domestic...
B1621 has a “constellation of mutations” that could help it escape the effects of vaccines – but evidence on its effects is currently limited.
Gene sequencing company Oxford Nanopore is preparing itself for an autumn IPO that should… The post British biotech Oxford Nanopore to launch autumn IPO for London...
A study published in The Lancet Infectious Diseases found that the Pfizer-BioNTech, Oxford-AstraZeneca or Moderna vaccines resulted in a drop in “long-haul” Covid-19 by 50 percent. According...
California-based Fulgent Genetics Inc. (FLGT) is a genetic testing company. It helps with the testing of cancers and infectious and rare diseases. Its tests also cover...
Tools for altering gene expression—CRISPRi, CRISPRa, CRISPRoff, and CRISPRon—and CRISPR-compatible cellular models are opening new research possibilities. The post CRISPR: New Techniques and Complex Models appeared...
Evonetix describes DNA synthesizer technology that will speed development across multiple therapeutic modalities. The post Synthetic DNA in Drug Discovery and Development appeared first on GEN...
While the progress we’ve seen in synthetic biology is exciting, we are not yet seeing the free-flowing innovation of a truly transformative wave, such as the...
Jumpcode Genomics offers a depletion technology that targets abundant or uninformative sequences. The post CRISPR-Cas9 Technology Cuts Clutter from Sequencing Libraries appeared first on GEN -...
Kevin Holden, PhD, Head of Science at Synthego, discusses the importance of industrializing CRISPR as the technology matures and makes inroads in the clinic. The post...
In this GEN webinar, our distinguished speaker Dr. Kathy Rowlen, CEO and co-founder of InDevR, will review critical quality attributes for mRNA vaccines, related CMC issues and explain...
A new study on Covid-19 behavior has found that patients affected by the virus might have died due to a buildup of coronavirus directly in the lungs and...